Phase I study of REGN421 (R)/SAR153192, a fully-human delta-like ligand 4 (Dll4) monoclonal antibody (mAb), in patients with advanced solid tumors.
Antonio Jimeno
Research Funding - Regeneron
Patricia LoRusso
Research Funding - Regeneron
Robert Matthew Strother
Research Funding - Regeneron
Jennifer Robinson Diamond
Research Funding - Regeneron
Leah Plato
Research Funding - Regeneron
Anne Younger
Research Funding - Regeneron
Wells A. Messersmith
Research Funding - Regeneron (B)
Muaiad Kittaneh
Research Funding - Regeneron
Doug Sawyer
Consultant or Advisory Role - Regeneron (U)
Lieve Adriaens
Employment or Leadership Position - Regeneron
Stock Ownership - Regeneron
Liming Liu
Employment or Leadership Position - Regeneron
Stock Ownership - Regeneron
Richard J. Kao
Employment or Leadership Position - Regeneron
Stock Ownership - Regeneron
A Thomas DiCioccio
Employment or Leadership Position - Regeneron
Stock Ownership - Regeneron
Carrie M. Brownstein
Employment or Leadership Position - Regeneron
Stock Ownership - Regeneron
Israel Lowy
Employment or Leadership Position - Regeneron
Stock Ownership - Regeneron
Pamela Trail
Employment or Leadership Position - Regeneron
Stock Ownership - Regeneron
E. Gabriela Chiorean
Research Funding - Regeneron